Marcus, J. L., Hurley, L. B., Chamberland, S., Champsi, J. H., Gittleman, L. C., Korn, D. G., . . . Silverberg, M. J. (2018). No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients. Clin Gastroenterol Hepatol.
Styl cytowania ChicagoMarcus, Julia L., et al. "No Difference in Effectiveness of 8 Vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients." Clin Gastroenterol Hepatol 2018.
Styl cytowania MLAMarcus, Julia L., et al. "No Difference in Effectiveness of 8 Vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients." Clin Gastroenterol Hepatol 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..